[
  {
    "ts": null,
    "headline": "Medtronic Delivers on FY25 Sustainability Targets and Charts Path to 2030",
    "summary": "A landmark year for the company's impact journey, Medtronic not only achieved but also exceeded its Scope 1 and 2 emissions intensity target in FY25 NORTHAMPTON, MA / ACCESS Newswire / October 8, 2025 / Medtronic plc, a global healthcare technology ...",
    "url": "https://finnhub.io/api/news?id=a7e598965ec69e03c8a7c5607ad68eeb7ee5c16c8b477b61b7c862dffcc43a5d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759940100,
      "headline": "Medtronic Delivers on FY25 Sustainability Targets and Charts Path to 2030",
      "id": 137013050,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "A landmark year for the company's impact journey, Medtronic not only achieved but also exceeded its Scope 1 and 2 emissions intensity target in FY25 NORTHAMPTON, MA / ACCESS Newswire / October 8, 2025 / Medtronic plc, a global healthcare technology ...",
      "url": "https://finnhub.io/api/news?id=a7e598965ec69e03c8a7c5607ad68eeb7ee5c16c8b477b61b7c862dffcc43a5d"
    }
  },
  {
    "ts": null,
    "headline": "Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change",
    "summary": "The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a",
    "url": "https://finnhub.io/api/news?id=085affccf98d8f236a1968cd463ac8ad784e85caaaba4a51236bf5de86a399e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759923960,
      "headline": "Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change",
      "id": 137010062,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a",
      "url": "https://finnhub.io/api/news?id=085affccf98d8f236a1968cd463ac8ad784e85caaaba4a51236bf5de86a399e1"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures",
    "summary": "Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to evaluate the safety and effectiveness of its Hugo™ robotic-assisted surgery (RAS) system in robotic-assisted gynecological procedures.",
    "url": "https://finnhub.io/api/news?id=e43093d93e7b2052a6dabc53a6f2a7f646db7f8615b781286b4fa82a366f0638",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759921200,
      "headline": "Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures",
      "id": 137010156,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to evaluate the safety and effectiveness of its Hugo™ robotic-assisted surgery (RAS) system in robotic-assisted gynecological procedures.",
      "url": "https://finnhub.io/api/news?id=e43093d93e7b2052a6dabc53a6f2a7f646db7f8615b781286b4fa82a366f0638"
    }
  },
  {
    "ts": null,
    "headline": "Citigroup Maintains Medtronic (MDT) Buy Recommendation",
    "summary": "Citigroup Maintains Medtronic (MDT) Buy Recommendation",
    "url": "https://finnhub.io/api/news?id=3504369b24fc71a19a42222dd8a20a727d5339c6c59efdbcd9184a7e76de403b",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759881944,
      "headline": "Citigroup Maintains Medtronic (MDT) Buy Recommendation",
      "id": 137005016,
      "image": "",
      "related": "MDT",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=3504369b24fc71a19a42222dd8a20a727d5339c6c59efdbcd9184a7e76de403b"
    }
  }
]